Evidence map›Paper›PMID 22183830›Full record

ArticleMagnetic resonance in medicine2012

Pharmacological MRI of the choroid and retina: blood flow and BOLD responses during nitroprusside infusion.

Yen-Yu I Shih, Guang Li, Eric R Muir, Bryan H De La Garza, Jeffrey W Kiel, Timothy Q Duong

Open access · bronzeAbstract read
In one paragraph

Article in Magnetic resonance in medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Neuromodulation in Small Animal fMRI.Journal of magnetic resonance imaging : JMRI · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yen-Yu I ShihResearch Imaging Institute, University of Texas Health Science Center, San Antonio, Texas 78229, USA. shihy@uthscsa.edu
Guang Li
Eric R Muir
Bryan H De La Garza
Jeffrey W Kiel
Timothy Q Duong
The University of Texas Health Science Center at San Antonio · US

Funding

INSTITUTE FOR INTEGRATION OF MEDICINE & SCIENCE: A PARTNERSHIP TO IMPROVE HEALTHUL1RR025767 · NCRR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A · 2008 to 2011
$23.8M
PATHOBIOLOGY OF OCCLUSIVE VASCULAR DISEASET32HL007446 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Jean Chrisostome Bopassa · 1985 to 2026
$8.9M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR000149 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A · 2012 to 2013
$6.8M
Ocular blood flow and intraocular pressure homeostasisR01EY009702 · NEI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI KIEL, JEFFREY W · 1992 to 2013
$3.3M
Layer-Specific Functional &Perfusion Imaging of RetinaR01EY014211 · NEI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DUONG, TIMOTHY Q. · 2004 to 2011
$3.0M
Layer-specific imaging of retinal degenerationR01EY018855 · NEI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DUONG, TIMOTHY Q. · 2009 to 2012
$769k
NCATS NIH HHS UL1 TR000149NCRR NIH HHS UL1 RR025767NCRR NIH HHS UL1RR025767NEI NIH HHS EY014211NEI NIH HHS EY018855NEI NIH HHS R01 EY009702NEI NIH HHS R01 EY014211NEI NIH HHS R01 EY018855NHLBI NIH HHS T32 HL007446
6 · The paper itself

Abstract

Nitroprusside, a vasodilatory nitric oxide donor, is clinically used during vascular surgery and to lower blood pressure in acute hypertension. This article reports a novel application of blood flow (BF) and blood oxygenation level dependent (BOLD) MRI on an 11.7T scanner to image the rat chorioretinal BF and BOLD changes associated with graded nitroprusside infusion. At low doses (1 or 2 μg/kg/min), nitroprusside increased BF as expected but decreased BOLD signals, showing an intriguing BF-BOLD uncoupling. At high doses (3-5 μg/kg/min), nitroprusside decreased BF and markedly decreased BOLD signals. To our knowledge, this is the first pharmacological MRI application of the retina. This approach has potential to open up new avenues to study the drug-related hemodynamic functions and to evaluate the effects of novel therapeutic interventions on BOLD and BF in the normal and diseased retinas.

Indexed as

AnimalsBlood Flow VelocityChoroidDose-Response Relationship, DrugInfusions, Intra-ArterialMagnetic Resonance ImagingMaleNitroprussideOxygenRatsRats, Long-EvansRetinaVasodilator AgentsNitroprussideOxygenVasodilator Agents

Identifiers

PMID22183830
PMCPMC3323760
OpenAlexW2168316477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.